MA49794A - Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire - Google Patents

Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire

Info

Publication number
MA49794A
MA49794A MA049794A MA49794A MA49794A MA 49794 A MA49794 A MA 49794A MA 049794 A MA049794 A MA 049794A MA 49794 A MA49794 A MA 49794A MA 49794 A MA49794 A MA 49794A
Authority
MA
Morocco
Prior art keywords
prophylactic
disorders
composition used
therapeutic treatment
cardiovascular system
Prior art date
Application number
MA049794A
Other languages
English (en)
Inventor
Elisa Brilli
Andrea Lacorte
Germano Tarantino
Original Assignee
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S P A filed Critical Pharmanutra S P A
Publication of MA49794A publication Critical patent/MA49794A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA049794A 2017-07-26 2018-07-26 Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire MA49794A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare

Publications (1)

Publication Number Publication Date
MA49794A true MA49794A (fr) 2020-06-03

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049794A MA49794A (fr) 2017-07-26 2018-07-26 Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire

Country Status (19)

Country Link
US (1) US20200206157A1 (fr)
EP (1) EP3657963A1 (fr)
JP (2) JP2020528888A (fr)
KR (1) KR20200032691A (fr)
CN (1) CN111031813A (fr)
BR (1) BR112020000902B1 (fr)
CA (1) CA3070659A1 (fr)
CL (1) CL2020000170A1 (fr)
CO (1) CO2020000526A2 (fr)
EA (1) EA202090069A1 (fr)
IL (1) IL272138B2 (fr)
IT (1) IT201700085412A1 (fr)
JO (1) JOP20200012A1 (fr)
MA (1) MA49794A (fr)
MX (1) MX2020000806A (fr)
PE (1) PE20200794A1 (fr)
PH (1) PH12020550031A1 (fr)
WO (1) WO2019021232A1 (fr)
ZA (1) ZA202000461B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
WO2019237053A1 (fr) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Méthodes et compositions destinés à la prévention ou au traitement de la calcification des tissus
AU2019282421B2 (en) 2018-06-08 2025-01-09 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
KR20250019094A (ko) 2022-05-31 2025-02-07 레지온 시드단마크 관상동맥 석회화(cac) 치료용 비타민 k2

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
WO1996039053A2 (fr) * 1995-06-06 1996-12-12 Campbell Soup Company Complements alimentaires a base de mineraux pour repas dietetique
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
JP4838139B2 (ja) * 2003-10-28 2011-12-14 エモリー ユニバーシティー 透析液並びに透析液に関連した方法及びシステム
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
CA2587391A1 (fr) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions utiles pour le traitement de maladies neovasculaires oculaires et la degenerescence maculaire
PT1973552T (pt) * 2005-12-23 2017-07-18 Gupta Ajay Composição para nutrição parenteral contendo ferro
EP1978807B1 (fr) * 2006-01-30 2016-03-23 Panion & BF Biotech Inc. Méthode de traitement de néphropathie chronique
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
CN102159222B (zh) * 2008-12-25 2014-08-06 I.B.E.有限会社 生物活性剂，药物，化妆品，保鲜剂，以及植物以及动物的发育促进剂
WO2012161572A1 (fr) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprenant de la vitamine k2
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
EP2886129A1 (fr) * 2013-12-20 2015-06-24 VitaK B.V. Prévention et action contraire de risque de thrombose induite par le régime alimentaire
WO2016131993A2 (fr) * 2015-02-20 2016-08-25 Vitak B.V. Vitamine k et fonction capillaire
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Also Published As

Publication number Publication date
PH12020550031A1 (en) 2021-02-08
JOP20200012A1 (ar) 2020-01-26
CA3070659A1 (fr) 2019-01-31
CO2020000526A2 (es) 2020-02-18
EA202090069A1 (ru) 2020-04-10
ZA202000461B (en) 2021-03-31
IL272138B2 (en) 2023-09-01
IL272138A (en) 2020-03-31
WO2019021232A1 (fr) 2019-01-31
IL272138B1 (en) 2023-05-01
JP2020528888A (ja) 2020-10-01
CN111031813A (zh) 2020-04-17
US20200206157A1 (en) 2020-07-02
CL2020000170A1 (es) 2020-10-30
PE20200794A1 (es) 2020-08-10
BR112020000902B1 (pt) 2024-03-12
BR112020000902A2 (pt) 2020-07-21
EP3657963A1 (fr) 2020-06-03
JP2023090869A (ja) 2023-06-29
MX2020000806A (es) 2020-08-17
KR20200032691A (ko) 2020-03-26
IT201700085412A1 (it) 2019-01-26

Similar Documents

Publication Publication Date Title
MA49794A (fr) Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire
EP3858977A4 (fr) Souche pour la prévention et le traitement de maladies métaboliques et utilisation associée
MA50417A (fr) Procédés d'utilisation d'inhibiteurs de l'ehmt2 dans le traitement ou la prévention de troubles du sang
EP3370748A4 (fr) Microbiote thérapeutique pour le traitement et/ou la prévention de l'allergie alimentaire
EP3612215A4 (fr) Compositions et procédés pour le traitement d'inflammation pulmonaire
MA50849A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
EP3723513A4 (fr) Probiotiques et métabolites de fermentation pour la prévention et le traitement d'états pathologiques chez des animaux
EP3481387A4 (fr) Methodes et compositions pour le traitement de troubles épileptiques
EP3448398A4 (fr) Compositions et méthodes pour le traitement de troubles cutanés
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA47688A (fr) Compositions utiles dans le traitement de l'amyotrophie spinale
MA45089A (fr) Utilisation d'indazoles 2-substitués pour le traitement et la prophylaxie de maladies auto-immunes
EP3639833A4 (fr) Agent pour la prévention ou le traitement de maladies liées à la graisse et/ou de l'inflammation
EP3463315A4 (fr) Compositions et méthodes d'utilisation de nintédanib pour le traitement de maladies oculaires à néovascularisation anormale
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
MA51056A (fr) Compositions et méthodes pour le traitement d'affections métaboliques
EP3512517A4 (fr) Utilisation de pridopidine pour le traitement de l'anxiété et de la dépression
MA47069A (fr) Formes pharmaceutiques contenant des inhibiteurs des canaux task-1 et task-3 et leur utilisation pour le traitement de troubles respiratoires
EP3348643A4 (fr) Interleukine 12 modifiée et utilisation de celle-ci dans la préparation de médicaments pour le traitement de tumeurs
MA44762A (fr) Sémaglutide utilisé dans le traitement de maladies cardiovasculaires
MA41996A (fr) Utilisation de triméthazine dans la préparation de médicaments pour la prévention et le traitement de maladies hépatiques
EP3876967A4 (fr) Microbiote thérapeutique pour le traitement et/ou la prévention d'une dysbiose
MA50233A (fr) Mic-1 et glp-1 destinés à être utilisés dans le traitement de l'obésité
MA47074A (fr) Formes pharmaceutiques comprenant des inhibiteurs de canaux de task-1 et task-3 et leur utilisation pour le traitement des troubles respiratoires
EP3833373A4 (fr) Tri-peptides et traitement de troubles métaboliques, cardiovasculaires et inflammatoires